Information Provided By:
Fly News Breaks for May 23, 2019
ELAN, CTB, GT, SCPL, TH, ALLO
May 23, 2019 | 10:10 EDT
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Elanco (ELAN) initiated with a Neutral at Guggenheim. 2. Cooper Tire (CTB) initiated with an Overweight at KeyBanc while Goodyear Tire (GT) was initiated with a Sector Weight. 3. SciPlay (SCPL) initiated with a Buy at Craig-Hallum and an Overweight at Stephens. 4. Target Hospitality (TH) initiated with an Outperform at Credit Suisse and Oppenheimer. 5. Allogene Therapeutics (ALLO) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
News For ELAN;CTB;GT;SCPL;TH;ALLO From the Last 2 Days
GT
Aug 16, 2019 | 10:04 EDT
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Merck (MRK) initiated with an Outperform at SVB Leerink. 2. DocuSign (DOCU) initiated with a Buy at DA Davidson. 3. iQIYI (IQ) initiated with an Underweight at JPMorgan. 4. Goodyear Tire (GT) initiated with an Outperform at Exane BNP Paribas. 5. BlackBerry (BB) initiated with a Neutral at Macquarie. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TH
Aug 16, 2019 | 07:06 EDT
Target Hospitality announced that its board has authorized a stock repurchase program of up to $75M. The authorization of the repurchase program is strategically consistent with the company's capital allocation priorities to simultaneously invest in growth, maintain a strong balance sheet, and deploy capital into value enhancing initiatives.
GT
Aug 16, 2019 | 05:17 EDT
Exane BNP Paribas started Goodyear Tire & Rubber with an Outperform rating and $15 price target.
ELAN
Aug 15, 2019 | 05:54 EDT
UBS analyst Navin Jacob upgraded Elanco Animal Health (ELAN) to Neutral from Sell with a price target of $30, down from $31. While the analyst still see risks to the company's fundamentals from African swine fever and generic Rumensin, he believes the shares are more fairly valued at current levels. Further, some of these headwinds may be offset by companion animal strength, Jacob tells investors in a research note. While concerns of a potential deal with Bayer (BAYRY) have pushed Elanco shares lower, "forecastable" concerns are built in at current levels, says the analyst.